Amid controversy and news of accelerated trials abroad, the latest report on Sputnik V suggests that the vaccine may meet its promised target and offers tolerable immunity after the first injection. Alexander Gintsburg, director of Moscow’s Gamaleya state research institute, which runs the trials, said that enough samples have been …
Read More »